Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700916 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
A Early Phase 1 study of Obesity and Dyslipidemias, sponsored by University of Connecticut.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT05700916: Recruiting Early Phase 1 study of Obesity and Dyslipidemias, sponsored by University of Connecticut.
NCT05700916 is a Early Phase 1 study of Obesity and Dyslipidemias that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 130 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05700916, a Early Phase 1 study of Obesity and Dyslipidemias, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Primary Outcome
Measurement of serum LDL cholesterol (mg/dL) at the beginning and end of 8-week intervention arm.
Conditions Studied
Interventions
- DRUG Milk Polar Lipid-Rich Dairy Powder
- DIETARY_SUPPLEMENT Dairy Powder
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
What NCT05700916 shows while recruiting
NCT05700916 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Milk Polar Lipid-Rich Dairy Powder is the first listed.
NCT05700916 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05700916 about?
NCT05700916 is a clinical study titled "Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity". The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
What is the current status of trial NCT05700916?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 130 participants. The study started on 2023-10-20. Estimated completion is 2026-06.
What conditions does trial NCT05700916 study?
This clinical trial studies the following conditions: Obesity, Dyslipidemias.
What interventions are being tested in trial NCT05700916?
The interventions under investigation include: Milk Polar Lipid-Rich Dairy Powder (DRUG), Dairy Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05700916?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05700916 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05700916's enrollment target sits among peer trials
130 418th of 1053 higher than 633 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
RECRUITING · Early Phase 1
-
Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
RECRUITING · Early Phase 1
-
Social Determinants of Sleep and Obesity
RECRUITING · Early Phase 1
-
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
RECRUITING · Early Phase 1
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI